Inmune Bio, Inc.
INMB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001711754
No open-market purchases or sales by Inmune Bio, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Inmune Bio, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 82 | 2 | 82 | +2 |
| Shares | 5.38M | 13.2K | 4.34M | −1.02M (−19.0%) |
| Value | $6.09M | $14.9K | $7.08M | +$1.01M (+16.7%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Inmune Bio, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 159,559 | $260.1K | 0.00% |
| Citadel Advisors LLC | 106,231 | $173.2K | 0.00% |
| HRT Financial LP | 84,358 | $137.0K | 0.00% |
| Gsa Capital Partners LLP | 81,991 | $134.0K | 0.01% |
| Virtu Financial LLC | 75,212 | $123.0K | 0.00% |
| Qube Research & Technologies Ltd | 40,773 | $66.5K | 0.00% |
| Abel Hall, LLC | 24,559 | $40.0K | 0.01% |
| Wealth Enhancement Advisory Services, LLC | 20,449 | $39.7K | 0.00% |
| StoneX Group Inc. | 21,513 | $30.6K | 0.00% |
| Mercer Global Advisors Inc | 17,809 | $29.0K | 0.00% |
| Point72 Asset Management, L.P. | 16,577 | $27.0K | 0.00% |
| LPL Financial LLC | 12,842 | $20.9K | 0.00% |
| HighTower Advisors, LLC | 12,664 | $20.6K | 0.00% |
| Creative Planning | 11,325 | $18.5K | 0.00% |
| Captrust Financial Advisors | 11,234 | $18.3K | 0.00% |
| Scientech Research LLC | 10,483 | $17.1K | 0.01% |
| National Bank of Canada | 2,000 | $3.28K | 0.00% |
| Cornerstone Planning Group LLC | 304 | $559 | 0.00% |
| Fortitude Family Office, LLC | 79 | $129 | 0.00% |
| Wealth Enhancement Trust Services, Inc. | 42 | $68 | 0.00% |
| US Bancorp | 25 | $41 | 0.00% |
| Clearstead Advisors, LLC | 17 | $28 | 0.00% |
| JPL Wealth Management, LLC | 6 | $10 | 0.00% |
Sold out (21)
Institutions that held Inmune Bio, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Vanguard Portfolio Management LLC | 129,218 | $146.0K |
| Charles Schwab Investment Management Inc | 50,252 | $56.8K |
| Quadrature Capital Ltd | 32,362 | $36.6K |
| Alliancebernstein L.P. | 21,950 | $34.2K |
| Bank of America Corp | 25,502 | $28.8K |
| Nuveen, LLC | 16,518 | $18.7K |
| Two Sigma Securities, LLC | 14,530 | $16.4K |
| Tower Research Capital LLC (TRC) | 11,772 | $13.3K |
| Mirae Asset Global ETFs Holdings Ltd. | 10,205 | $11.5K |
| GWM Advisors LLC | 5,000 | $5.65K |
| Vanguard Global Advisers, LLC | 4,539 | $5.13K |
| MAI Capital Management | 4,271 | $4.83K |
| Police & Firemen's Retirement System of New Jersey | 3,357 | $3.79K |
| Legal & General Group Plc | 1,520 | $1.72K |
| Ameritas Investment Partners, Inc. | 1,196 | $1.35K |
| New York State Common Retirement Fund | 500 | $565 |
| Deutsche Bank AG | 296 | $334 |
| Optiver Holding B.V. | 146 | $165 |
| Sterling Capital Management LLC | 136 | $154 |
| Root Financial Partners, LLC | 87 | $98 |
| Wealth Preservation Advisors, LLC | 60 | $68 |
Not filed for Q2 2026 yet (2)
Institutions that held Inmune Bio, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 13,120 | $14.8K |
| Sunbelt Securities, Inc. | 34 | $38 |